Frederique Chedevergne
Paris, 75743, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Fat-Soluble Vitamin Status in 2 to 5 Year-Old Children Using a Cystic Fibrosis-Specific Multivitamin Formulation.
Journal: Children (Basel, Switzerland)
Published: May 24, 2026
Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR.
Journal: Frontiers in pharmacology
Published: July 07, 2025
Impact of a Cystic Fibrosis Specific Multivitamin Formulation on Fat-Soluble Vitamin Status and Treatment Satisfaction in Young Children.
Journal: Children (Basel, Switzerland)
Published: June 17, 2025
First real-world study of fetal therapy with CFTR modulators in cystic fibrosis: Report from the MODUL-CF study.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: December 15, 2024
Short-term modification of breathprint by Elexacaftor/Tezacaftor/Ivacaftor in a paediatric cohort.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 24, 2024
Theratyping cystic fibrosis patients to guide elexacaftor/tezacaftor/ivacaftor out-of-label prescription.
Journal: The European respiratory journal
Published: January 18, 2023
Proteomic profiling of sweat in patients with cystic fibrosis provides new insights into epidermal homoeostasis.
Journal: Skin health and disease
Published: June 23, 2022
Profiling the response to lumacaftor-ivacaftor in children with cystic between fibrosis and new insight from a French-Italian real-life cohort.
Journal: Pediatric pulmonology
Published: April 22, 2022
Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis.
Journal: The European respiratory journal
Published: May 11, 2021
Lumacaftor-ivacaftor effects on cystic fibrosis-related liver involvement in adolescents with homozygous F508 del-CFTR.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: December 05, 2020
"Il faut continuer à poser des questions" patient reported outcome measures in cystic fibrosis: An anthropological perspective.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 20, 2020
Prevention of osteoporosis in cystic fibrosis.
Journal: Current opinion in pulmonary medicine
Published: October 01, 2019
Last Updated: 09/26/2026